Gene · 3385
ICAM3: intercellular adhesion molecule 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ICAM3: intercellular adhesion molecule 3. Genes, record 3385. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3385
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P32942 | Intercellular adhesion molecule 3 | 547 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents104
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 12595486 B2 | 2026-04-07 | 231 | P32942 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 50027 | P32942 | Espacenet |
| JP 2026500896 A | 2026-01-09 | 4 | P32942 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 117 | P32942 | Espacenet |
| WO 2025235604 A1 | 2025-11-13 | 4 | P32942 | Espacenet |
| WO 2025235605 A1 | 2025-11-13 | 4 | P32942 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 12 | P32942 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 92 | P32942 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2026 | P32942 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2026 | P32942 | Espacenet |
1 to 10 of 104
See all 104 patentsDrugs1
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action |
|---|---|---|---|
| ICM3 | CHEMBL2109481 | Intercellular adhesion molecule 3 inhibitor | INHIBITOR |
Source ChEMBL
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,126
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ICAM3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| ZIAHD002400 | The Role Of Subclinical Infection And Cytokines In Preterm Parturition | 4 | 2025 |
| P20GM103475 | Advancing Competitive Biomedical Research in Puerto Rico | 2 | 2025 |
| P30AI027757 | University of Washington/Fred Hutch Center for AIDS Research | 2 | 2025 |
| P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 2 | 2025 |
| P30AI064518 | Center for AIDS Research | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,126Source NIH's project files
See all 1,126 nih grantsPapers1,776
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and Validation of an Anoikis-Related Machine Learning Signature for Prognosis and Brain Metastasis-Associated Classification in Lung Adenocarcinoma. | Cancers (Basel) | 2026 | 42352501 | PubTator, text mining | PubMed |
| A Coordinated Adhesion-Molecule Activation Profile in Pediatric Sepsis: A Prospective Cohort Study from Vietnam. | Pediatr Rep | 2026 | 42347075 | PubTator, text mining | PubMed |
| Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatment. | Pulmonology | 2026 | 42324975 | PubTator, text mining | PubMed |
| TM4SF1 regulates esophageal squamous cell carcinoma KYSE150 cell phenotypes via miRNA-regulated pathways. | Cytotechnology | 2026 | 42040328 | PubTator, text mining | PubMed |
| Sex differences in proteomic response to ischemic stroke. | Biol Sex Differ | 2026 | 42002779 | PubTator, text mining | PubMed |
| RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs. | J Immunother Cancer | 2026 | 41912267 | PubTator, text mining | PubMed |
| Solubility based mechanistic profiling of combinatorial drug therapy. | Nat Commun | 2026 | 41882025 | PubTator, text mining | PubMed |
| Aberrant fucosylation of extracellular vesicles remodels the vascular microenvironment and promotes chemoresistance in myelodysplastic syndromes and acute myeloid leukemia. | Haematologica | 2026 | 41784036 | PubTator, text mining | PubMed |
| Marine-Derived Defenses Against HIV: Emerging Bioactive Molecules from the Seas. | Mar Drugs | 2026 | 41745473 | PubTator, text mining | PubMed |
| Innovative approaches targeting innate immune cells to promote organ transplant tolerance. | Front Transplant | 2026 | 41737588 | PubTator, text mining | PubMed |
1 to 10 of 1,776
See all 1,776 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3385
GET https://conductscience.org/api/genes/v1/3385/patents?page=2